Bespoke Extracts, Inc. (BSPK) financial statements (2021 and earlier)

Company profile

Business Address 323 SUNNY ISLES BOULEVARD
SUNNY ISLES, FL 33160
State of Incorp. NV
Fiscal Year End August 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in thousands)

11/30/2019
TTM
8/31/2019
8/31/2018
8/31/2017
8/31/2016
8/31/2015
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments821080870186
Cash and cash equivalents821080870186
Receivables462   
Inventory, net of allowances, customer advances and progress billings1362   
Inventory1362   
Prepaid expense12183120  
Other undisclosed current assets     21
Total current assets:98381751070207
Noncurrent Assets
Intangible assets, net (including goodwill)    1 
Intangible assets, net (excluding goodwill)    1 
Regulated entity, other noncurrent assets1,8942,056    
Other undisclosed noncurrent assets(1,853)(2,014)4549 76
Total noncurrent assets:41424549176
TOTAL ASSETS:139792201562283
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities, including:151111105376932
Other undisclosed accounts payable and accrued liabilities151111105376932
Debt18 461   
Due to related parties 004546 
Other undisclosed current liabilities   153  
Total current liabilities:16911156623511632
Noncurrent Liabilities
Long-term debt and lease obligation  81193  
Long-term debt, excluding current maturities  81193  
Total noncurrent liabilities:  81193  
Total liabilities:16911164742811632
Stockholders' equity
Stockholders' equity attributable to parent, including:(30)(32)(428)(272)(114)251
Common stock105784327  
Additional paid in capital14,34113,95016,2468,8082,3112,101
Accumulated deficit(14,552)(14,136)(16,717)(9,107)(2,428)(2,063)
Other undisclosed stockholders' equity attributable to parent7676  3212
Total stockholders' equity:(30)(32)(428)(272)(114)251
TOTAL LIABILITIES AND EQUITY:139792201562283

Income statement (P&L) ($ in thousands)

11/30/2019
TTM
8/31/2019
8/31/2018
8/31/2017
8/31/2016
8/31/2015
Revenues756216   
Cost of revenue
(Cost of Goods and Services Sold)
(61)(71)(23)   
Other undisclosed gross profit(52)     
Gross profit:(38)(9)(7)   
Operating expenses(1,360)3,024(7,184)(6,616)(365)(731)
Operating income (loss):(1,398)3,014(7,191)(6,616)(365)(731)
Nonoperating expense(291)(433)(419)(63)  
Interest and debt expense(291)(357)(419)(28)(0) 
Income (loss) from continuing operations before equity method investments, income taxes:(1,981)2,223(8,029)(6,707)(365)(731)
Other undisclosed income from continuing operations before income taxes29135741928  
Net income (loss) available to common stockholders, diluted:(1,689)2,581(7,610)(6,679)(365)(731)

Comprehensive Income ($ in thousands)

11/30/2019
TTM
8/31/2019
8/31/2018
8/31/2017
8/31/2016
8/31/2015
Net income (loss):(1,689)2,581(7,610)(6,679)(365)(731)
Comprehensive income (loss), net of tax, attributable to parent:(1,689)2,581(7,610)(6,679)(365)(731)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: